Eden Innovations Ltd · ASX:EDE

Eden Innovations — Investor Presentation (November 2016)

31 slides from Eden Innovations's investor presentation, November 2016

  1. Slide 1: Investor Presentation

    Investor Presentation November 2016 EDE. ASX

  2. Slide 2: Disclaimer

    Disclaimer 2 FORWARD LOOKING STATEMENTS This presentation includes certain forward-looking statements of Eden’s management. Forward-looking statements are statements that contemplate the happening of possible future events and are not based on historical fact. Forward-looking statements may be ident

  3. Slide 3: Company Highlights

    Company Highlights 3 . Innovations that work. EDE.ASX

  4. Slide 4: Capital Structure

    Capital Structure 4 Issuer Eden Innovations Limited Symbol/ Exchange EDE. ASX Issued shares 1,253,544,739 Stock Price (1) A$0.23 Market Cap (1) A$330 million (2) Cash (1) ≈A$20.8 million Debt Nil 1) As of 23 November 2016 2) Incl EDEO 215m Ex @ 3c 30.9.18 Innovations that work. EDE.ASX

  5. Slide 5: Board of Directors and Senior Management

    Board of Directors and Senior Management 5 Board of Directors • Greg Solomon LLB - Executive Chairman • Richard Beresford BSc (Mech Eng), MSc (Technology and Development) FAICD, FAIE • Guy Le Page BA, BSc(Hons), MBA, ASIA, MAusIMM • Doug Solomon LLB (Hons), B. Juris. Company Secretary/ CFO • Aaron G

  6. Slide 6: Company Products

    Company Products 6 Innovations that work. EDE.ASX

  7. Slide 7: Carbon Nanotubes (CNT) in Concrete

    Carbon Nanotubes(CNT) in Concrete 7 • Tensile Strength: 200-300x steel • Weight: ≈ 17% of steel • Strengthens concrete, plastics TEM image of Eden’s MWCNT •CNT provide:  Nucleation points for dense, cement hydration that builds on surface of CNT (see image)  Ultra-strong nano-scale fibre re-enforc

  8. Slide 8: Products comparison for concrete performance

    Increases Increases Increases Reduces Reduces Increases 8 Products Compres Split- Flexural Shrinkage Permeability Abrasion Drawback sive Tensile Strength Resistance Strength Strength None Fibers Reduced workability, (PP,PVA,ACRY,LOK difficult to handle ) Shrinkage Reducers Strength reduction, expens

  9. Slide 9: CNT in Concrete Applications

    9 CNT in Concrete Applications Increased Abrasion Resistance Lower Permeability / Lower Increased Compressive Shrinkage and Tensile Strength Road & bridges surfaces Roads, bridges, runways High rise buildings, bridges, Coastal and marine applications retaining walls, pre-fabricated pavements, floors

  10. Slide 10: U.S and Australian Concrete Trials 2015-16

    10 U.S and Australian Concrete Trials 2015-16 EdenCrete™ Reference Innovations that work. EDE.ASX

  11. Slide 11: U.S and Australian Concrete Trials 2015-16

    U.S and Australian Concrete Trials 2015-16 11 EdenCrete™ Reference Innovations that work. EDE.ASX

  12. Slide 12: ASTM C494 “S” – Results to 180 days

    ASTM C494 “S” – Results to 180 days 12 Testing by Intelligent Concrete LLC. Intelligent Concrete is entitled to receive royalties on sales of EdenCreteTM % Increase of EdenCreteTM (4gal/yd3) Over Reference Age (Days) Test 1 3 7 28 56 90 180 365 Compressive Strength (ASTM C39) 25% 35% 39% 41% 41% 39%

  13. Slide 13: EdenCrete™ – Abrasion Resistance

    EdenCrete™ – Abrasion Resistance 13 EdenCrete™ Reference Innovations that work. EDE.ASX

  14. Slide 14: GDOT I-20 Trial

    GDOT I-20 Trial August 2015 Improvement with EdenCrete™ • Compressive Strength - 45.8% at 56 days • Abrasion resistance – 56% at 56 days (20 min trial) Outcomes • GDOT approval to use in 24hr mix B class concrete • 2nd field trial, class A concrete Q2/Q3 2016 Innovations tha ED

  15. Slide 15: GDOT I-20 Field Trial – Update October 2016

    GDOT I-20 Field Trial – Update October 2016 15 EdenCrete™ – No Visible Cracking Control – Visible Crack Across Slab Innovations that work. EDE.ASX

  16. Slide 16: Anticipated Cumulative Cost Comparison

    16 Anticipated Cumulative Cost Comparison* Cost Benefit Analysis  Projected Extra Cost For GDOT  GDOT costs /yd3 ≈ 3% - 20%  Application Rate will vary for different targeted applications  Anticipated Increased Service Life >100%  Anticipated IRR < 50%+  Using EdenCrete™ , 60% more repairs ach

  17. Slide 17: Anticipated Cumulative Cost Comparison

    17 Anticipated Cumulative Cost Comparison* $45,000 $40,000 $35,000 $30,000 $25,000 $20,000 $15,000 $10,000 $5,000 $0 0 10 20 30 40 Years REFERENCE CONCRETE EDENCRETE500 * Based on GDOT actual costs for I-20 Field Trial Innovations that work. EDE.ASX

  18. Slide 18: EdenCrete™ Performance versus Dose (Gallons per Yard)

    EdenCrete™ Performance versus Dose (Gallons per Yard) 18 Dosage Abrasion Compressive Flexural Tensile Resistance Shrinkage Gallons/yd³ * 1/8 15% 5% 7% 5% 6% 1/4 17% 7% 12% 13% 18% 1/2 19% 9% 16% 31% 22% 1 19% 11% 21% 33% 24% 2 28% 16% 27% 40% 27% 3 27% 26% 33% 43% 29% 4 41% 32% 46% 59% 39% * 1 gallo

  19. Slide 19: EdenCrete™ – First Commercial Project

    EdenCrete™ – First Commercial Project 19 Ultra High Wear /Abrasion Resistance Application Control Trial Slab Typical ultra high load/ EdenCrete Trial Slab Significant cracks and abrasive application at site No cracks of evidence of wear after 6 months wear Innovations that work. EDE.ASX

  20. Slide 20: EdenCrete™ – First Commercial Project

    20 EdenCrete™ – First Commercial Project Ultra High Wear/Abrasion Resistance Application • 50% thickness vs new ultra high strength slab • Only EdenCreteTM used (no steel mesh or rebar) • No significant sub-base preparations • At least a comparable 5-year service life expected • Total cost saving of

  21. Slide 21: First Commercial EdenCrete™ Infrastructure Contract

    First Commercial EdenCrete™ Infrastructure Contract 21 Georgia MARTA Bus Garage – Atlanta, GA Innovations that work. EDE.ASX

  22. Slide 22: First Commercial EdenCrete™ Infrastructure Project

    First Commercial EdenCrete™ Infrastructure Project 22 Georgia MARTA Bus Garage • Results – Dosage rate: 3 gallons/ yard³  Compressive Strength Increase - 38%  Split Tensile Strength Increase - 59%  Modulus of Elasticity Increase - 24%  Abrasion Resistance Increase - 47%  Shrinkage Reduction - 9

  23. Slide 23: U.S Marketing Update – Initial Targets

    U.S Marketing Update – Initial Targets 23 Interstate Highways (≈73,000km*) / Bridges (≈605,000) • Use ≈40% of U.S cement * • ≈US$40 billion p.a. preservation/maintenance bill ** • 146,418 or 24% of bridges are structurally deficient/ functionally obsolete *** • Annual extra costs to motorists - US$6

  24. Slide 24: U.S Infrastructure Marketing - Georgia

    U.S Infrastructure Marketing - Georgia 24 • GDOT - Approved for road repairs - awaiting contract and trial for new roads - Discussing bridge applications - 14,700 bridges - 2,600 structurally deficient/ functionally obsolete* - US$1.1bn p.a. budget - planned 76 lane miles trucks US$2.06bn - 200 brid

  25. Slide 25: U.S Infrastructure Marketing – Other Progress

    U.S Infrastructure Marketing – Other Progress 25 US State DOTs other than GDOT • Approval process started with other DOTs for roads and bridges • Trials for precast bridge beams commenced • Approval for use in further state DOTs likely in 2016 and 2017 - ASTM C494 “S” – Testing to be completed in ea

  26. Slide 26: U.S Sales and Marketing

    U.S Sales and Marketing 26 Sales Team – Coverage of All Continental U.S • Senior Vice President of Business Development appointed • 9 sales staff – 2 managers / 6 salespeople/ 1 technical sales support Over 20 Trials across US - Infrastructure and Non- Infrastructure • Pervious concrete – underway •

  27. Slide 27: U.S Production Scale-Up

    U.S Production Scale-Up 27 Location Est. Cost US $ Estimated Estimated Start Date Date To Anticipated Output U.S p.a. Value(2) Complete Source of Funds U.S $ p.a. Colorado Funding 108,000 galls p.a. $2.7m Q1 2016 Q2 2016 Equity Stage 1 Complete (completed) Colorado Funding ≈2.4m galls p.a. $50m-62m

  28. Slide 28: U.S Production Scale-Up - Progress

    U.S Production Scale-Up - Progress 28 Colorado Production • Stage 2 Scale-up in Colorado on schedule for completion March 2017 • Planning underway for possible, low cost, further expansion of Colorado production capacity, if needed to cover any future production shortages until proposed Georgia plan

  29. Slide 29: CNT in Plastics / Polymers

    29 CNT in Plastics / Polymers UQ/ Eden- ARC Linkage Research Project Highly Encouraging Preliminary Results with CNT in Nylon 6 • Excellent combination of high modulus (stiffness) and outstanding ductility. • Superior ductility /comparable tensile strength vs super-tough commercial Nylons. • Higher

  30. Slide 30: CNT in Plastics / Polymers Cont.

    30 CNT in Plastics / Polymers Cont. UQ/ Eden- ARC Linkage Research Project Highly Encouraging Preliminary Results with CNT in Nylon 6 • Visual clarity and transparency – potentially suitable for a super-tough-film grade. • Relatively low-cost processing method. • Possible suitable future markets - a

  31. Slide 31: Greg Solomon

    31 Greg Solomon Executive Chairman Level 15, 197 St. Georges Terrace, Perth, Western Australia Tele: +618 9282 5889 Email: gsolomon@edeninnovations.com edeninnovations.com EDE.ASX Innovations that work. EDE.ASX

Eden Innovations — Investor Presentation (November 2016) on 6ix